LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Light-Enhanced Microneedle Vaccine Prevents Melanoma Development

By LabMedica International staff writers
Posted on 20 Nov 2017
Image: Melanin protein (light refracting granular material at the center of the photomicrograph) in a pigmented melanoma (Photo courtesy of Wikimedia Commons).
Image: Melanin protein (light refracting granular material at the center of the photomicrograph) in a pigmented melanoma (Photo courtesy of Wikimedia Commons).
A novel immunotherapeutic vaccine prevented the development of skin cancer in a mouse model by exploiting the ability of the protein melanin to transform light energy into heat.

Melanin is capable of transforming 99.9% of the absorbed sunlight energy into heat, which reduces the risk of skin cancer. In order to exploit this property, investigators at the University of North Carolina (Chapel Hill, USA) developed a melanin-mediated cancer immunotherapy strategy using a transdermal microneedle patch. A whole cell lysate prepared from cells of the B16F10 melanoma was augmented with melanin, and this mixture was loaded into polymeric microneedles that allowed sustained release of the lysate upon insertion into the skin.

The investigators used near-infrared light (IR) irradiation to induce the melanin in the patch to generate heat, which promoted tumor-antigen uptake by dendritic cells, and led to enhanced antitumor vaccination.

In a paper published in the November 10, 2017, online edition of the journal Science Immunology, the investigators reported that they divided a population of mice into three groups: one group was treated with the patch and was exposed to IR light; one group was treated with the patch, but was not exposed to IR light; and one group was treated with a patch that did not contain the cell lysate-melanin mixture. Ten days after initiation of the patch treatment, the mice were injected with active melanoma cells. Within one month, all of the mice that had received the empty patch died from melanoma. The lysate patch without exposure to near IR light was only slightly protective and only 13% of the mice survived. In contrast, 100% of the mice that had been treated with the active lysate patch and IR light survived after two months, and no tumors were detected in 87% of the animals. The enhanced results generated by exposure to IR light was attributed to local heating that caused formation of a fever-like environment in the skin, which promoted release of lysate from the microneedles, effectively attracting and activating immune cells.

"Melanin is a natural pigment that can efficiently transform absorbed sunlight energy into heat," said senior author Dr. Zhen Gu, professor of medicine at the University of North Carolina. "We demonstrated that melanin, which is found at high levels in melanoma, can actually be used to help treat melanoma. We do this by shining near infrared (IR) light on a therapeutic skin patch, which promotes the systemic immune response that fights cancer. These results are encouraging, but we are in the early stages of development. The next step would be a large animal study to further evaluate the safety and efficacy of the technique. And while it is much too early to estimate cost, we think that the treatment could be scaled up and would be affordable."

Related Links:
University of North Carolina

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Automated MALDI-TOF MS System
EXS 3000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more